PR: WILEX’s partner Link Health submits IND application for clinical Phase I with the uPA inhibitor MESUPRON® in China
- PDF File: images/files/press-releases-and-ad-hoc-announcements/20160113_pr_link-health-ind-mesu_final.pdf
- Datum: Wednesday, 13 January 2016 11:58
- Erstellt am .
- Geändert am .
- Aufrufe: 756